Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae type b

被引:113
作者
Pickering, JW
Martins, TB
Schroder, MC
Hill, HR
机构
[1] Associated Reg & Univ Pathologists Inst, Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA
[2] Univ Utah, Sch Med, Dept Pathol Pediat & Med, Salt Lake City, UT 84108 USA
关键词
D O I
10.1128/CDLI.9.4.872-876.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We developed a multiplexed indirect immunofluorescence assay for antibodies to Haemophilus influenza type b (Hib) polysaccharide and the toxoids of Clostridium tetani (Tet) and Corynebacterium diphtheriae (Dip) based on the Luminex multiple-analyte profiling system. A pooled serum standard was calibrated against World Health Organization standards for Dip and Tet and an international standard for Hib. The multiplexed Luminex assay was compared to individual enzyme-linked immunosorbent assays (ELISAs) for the same analytes. By both methods, 75 (92.6%) of 81 of random serum samples had protective levels of antibody to Tet (greater than or equal to0.1 IU/ml). For Dip, 81.5% of the samples had protective antibody levels (greater than or equal to0.1 IU/ml) by ELISA and 80.2% had protective antibody levels by Luminex. Protective levels (greater than or equal to1.0 mug/ml) of antibody to Hib were found in 45.0% of the samples tested by ELISA and in 39.0% of the samples tested by Luminex. The correlations (R-2) between ELISA and Luminex of the 81 samples were 0.96, 0,96, and 0.91 for Tet, Dip, and Hib, respectively. There was also similar agreement between Luminex and ELISA for sera collected before and 1 month after Tell, Dip, and Hib vaccine administration. Both methods detected strong postvaccination responses. The Luminex method is an attractive alternative to ELISA since it reduces labor and reagent costs, as well as assay time.
引用
收藏
页码:872 / 876
页数:5
相关论文
共 12 条
[1]  
ANDERSON P, 1984, J INFECT DIS, V149, P1034, DOI 10.1093/infdis/149.6.1034
[2]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V50, P7
[3]   Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay [J].
Concepcion, NF ;
Frasch, CE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (02) :266-272
[4]   Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants [J].
Dagan, R ;
Eskola, J ;
Leclerc, C ;
Leroy, O .
INFECTION AND IMMUNITY, 1998, 66 (05) :2093-2098
[5]   Combination vaccines: Problems and promise [J].
Decker, AD ;
Edwards, KM .
JOURNAL OF PEDIATRICS, 2000, 137 (03) :291-295
[6]   Combination vaccines [J].
Edwards, KM ;
Decker, MD .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2001, 15 (01) :209-+
[7]  
KAYHTY H, 1983, J INFECT DIS, V147, P1109
[8]   Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay [J].
Madore, DV ;
Anderson, P ;
Baxter, BD ;
Carlone, GM ;
Edwards, KM ;
Hamilton, RG ;
Holder, P ;
Kayhty, H ;
Phipps, DC ;
Peeters, CCA ;
Schneerson, R ;
Siber, GR ;
Ward, JI ;
Frasch, CE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (01) :84-88
[9]   AN ELISA EMPLOYING A HAEMOPHILUS-INFLUENZAE TYPE-B OLIGOSACCHARIDE-HUMAN SERUM-ALBUMIN CONJUGATE CORRELATES WITH THE RADIOANTIGEN BINDING ASSAY [J].
PHIPPS, DC ;
WEST, J ;
EBY, R ;
KOSTER, M ;
MADORE, DV ;
QUATAERT, SA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 135 (1-2) :121-128
[10]  
Pickering JW, 2002, AM J CLIN PATHOL, V117, P589